Sign Up Today and Learn More About Areteia Therapeutics Stock
Invest in or calculate the value of your shares in Areteia Therapeutics or other pre-IPO companies through EquityZen's platform.
Areteia Therapeutics Stock (ARET)
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
About Areteia Therapeutics Stock
Founded
2022
Headquarters
Bernardsville, NJ, US
Industries
Software, Artificial Intelligence, Data and Analytics
Areteia Therapeutics Press Mentions
Stay in the know about the latest news on Areteia Therapeutics
Global VC investment falls to lowest level in 5 years - KPMG Global
kpmg • May 24, 2024
Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic ...
businesswire • Apr 08, 2024
Most-Active US Investors: Andreessen Horowitz, GV And Alumni Have Big February
news • Mar 11, 2024
Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic ...
finance • Mar 01, 2024
North Carolina biotech tops $400M in funding for asthma treatment - Triangle Business Journal
bizjournals • Mar 01, 2024
Areteia Therapeutics Management
Leadership team at Areteia Therapeutics
Board Member
Adam Koppel
Board Member
Paul L Berns
Join now and verify your accreditation status to gain access to:
- Areteia Therapeutics current valuation
- Areteia Therapeutics stock price
- Available deals in Areteia Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Areteia Therapeutics Stock
How to invest in Areteia Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Areteia Therapeutics through EquityZen funds. These investments are made available by existing Areteia Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Areteia Therapeutics stock?
Shareholders can sell their Areteia Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
